Purpose of Study
To evaluate the clinical efficacy and safety of the IASD System II in symptomatic heart failure patients with the LV ejection fraction of > 40%, and elevated left-sided filling pressures.
In follow up
NYHA classification II – IV, 40 years or older, LV ejection fraction of > 40% within past 6 months, 1 heart failure hospital admission within the past 12 months.
Duration of Participation
Approximately 5 years
Contact Name: Megan Murphy, RN
Contact Phone: 515-235-5089
Contact Email: email@example.com